XYNOS KONSTANTINOS (Chief Medical Officer) sold 6.2% of their position (7.25K shares) of REPLIMUNE GROUP, INC. on the open market
Open‑market sale worth $78.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2024ACC: 0001104659-24-121188
Officer· Chief Medical Officer
Since Dec 2022
-7.25K
Net shares
Net seller
$78.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.25K
Price / share
$10.78
Trade value
$78.11K
% of position
6.2%
11/18/2024
117.13K→109.89K
Total
Net shares
−7.25K
Net value
-$78.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2024 | S · Sale | −7.25K | $10.78 | $78.11K | 6.2% | 117.13K | 109.89K |
| Total | −7.25K | -$78.11K | ||||||
Derivative Transactions0
No derivative transactions reported